Feasibility of administering Tegeline® at home: Retrospective study of the data concerning efficacy, safety and tolerance;Faisabilité de la substitution à domicile par Tégéline®: Étude rétrospective sur des données d'efficacité, de sécurité et de tolérance

Presse Medicale

Volumn 33, Issue 10, 2004, Pages 682-688

  Debre M ^a   Clairicia, M ^a   Bonnaud, F ^b   Jubin, O ^b   Thiebaux Boucard D ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b LFB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HOME CARE; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFECTION; MALE; PATIENT EDUCATION; PATIENT SELECTION; RETROSPECTIVE STUDY;

EID: 3042585048     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(04)98714-3     Document Type: Article

References (12)

1. Abrahamsen TG, Sandersen H, Bustnes A. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics 1996; 98: 1127-31.
2. Brenna NV. Home self-infusion of IV immunoglobulin. Nursing Standard 1991; 5: 37-9.
3. Brennan VM, Cochrane S, Fletcher C et al. Surveillance of adverse reactions in patients self-infusing intravenous immunoglobulin at home. J Clin Immunol 1995; 15: 116-19.
4. Cochrane S. Care of patients undergoing immunoglobulin therapy. Nursing Standard 1997; 11: 44-6.
5. Hachulla E, Wibaux A, Hatron PY et al. Home sequential high dose intravenous immunoglobulins in systemic autoimmune disease. Ann Rheum Dis 2002; 61: 277-8.
6. Haeney M. Intravenous immune globulin in primary immunodeficiency. Clin Exp Immunol 1994; 97(suppl. 1): 11-15.
7. Kobayashi RH, Kobayashi AD, Lee N et al. Home self-administration of intravenous immunoglobulin therapy in children. Pediatrics 1990; 85: 705-709.
8. Rosen FS, Eibl M, Roifman C. Primary immunodeficiency diseases-report of an IUI5 Scientific Committee. Clin Exp Immunol 1999; 118 (suppl. 1): 1-28.
9. Sewell WAC, Brennan VM, Donaghy M et al. The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies. J Neurol Neurosurg Psychiatry 1997; 63: 106-9.
10. Rosen FS, Cooper MD, Wedgwood RP. The primary immunodeficiencies. N Engl J Med 1995; 333: 431-40.
11. ElJkhout H, Van Der Meer J, Kallenberg C et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann Intern Med 2001; 135: 165-74.
12. Quartier P, Debre M, De Blic J et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999; 134: 589-96.